Control of Cardiovascular Risk Factors Among US Adults With Type 2 Diabetes With and Without Cardiovascular Disease

American Journal of Cardiology

Volumn 124, Issue 4, 2019, Pages 522-527

  Andary, Rana ^a,b   Fan, Wenjun ^a,b   Wong, Nathan D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; UNITED STATES; AGED; MIDDLE AGED; NUTRITION; RISK FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; RISK FACTORS; UNITED STATES;

EID: 85067579566     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2019.05.035     Document Type: Article

References (18)

1. Gaede, P, Oellgaard, J, Carstensen, B, Rossing, P, Lund-Andersen, H, Parving, HH, Pedersen, O, Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial. Diabetologia 59 (2016), 2298–2307.
2. Bittner, V, Bertolet, M, Barraza Felix, R, Farkouh, ME, Goldberg, S, Ramanathan, KB, Redmon, JB, Sperling, L, Rutter, MK, Bari 2D Study Group. Comprehensive cardiovascular risk factor control improves survival: the BARI 2D trial. J Am Coll Cardiol 66 (2015), 765–773.
3. Pagidipati, NJ, Navar, AM, Pieper, KS, Green, JB, Bethel, MA, Armstrong, PW, Josse, RG, McGuire, DK, Lokhnygina, Y, Cornel, JH, Halvorsen, S, Strandberg, TE, Delibasi, T, Holman, RR, Peterson, ED, TECOS Study Group. Secondary prevention of cardiovascular disease in patients with type 2 diabetes mellitus: international insights from the TECOS trial (Trial Evaluating Cardiovascular Outcomes with Sitagliptin). Circulation 136 (2017), 1193–1203.
4. Hamada, S, Gulliford, MC, Multiple risk factor control, mortality and cardiovascular events in type 2 diabetes and chronic kidney disease: a population-based cohort study. BMJ Open, 8, 2018, e019950.
5. Rawshani, A, Franzén, S, Sattar, N, Eliasson, B, Svensson, AM, Zethelius, B, Miftaraj, M, McGuire, DK, Rosengren, A, Gudbjörnsdottir, S, Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 379 (2018), 633–644.
6. Wong, ND, Patao, C, Wong, K, Malik, S, Franklin, SS, Iloeje, U, Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: comparison by prevalent cardiovascular disease status. Diabetes Vasc Dis Res 10 (2013), 505–513.
7. National Health and Nutrition Examination Survey: Sample Design, 2011–2014, Centers for Disease Control and Prevention.
8. National Center for Health Statistics, Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey: Laboratory Medical Technologists Procedures Manual. 2003–2004, US Department of Health and Human Services, Centers for Disease Control and Prevention, Hyattsville, MD.
9. American Diabetes Association. Glycemic targets. Diabetes Care 42:Suppl.1 (2019), s61–S70.
10. American Diabetes Association. Cardiovascular disease and risk management. Diabetes Care 42:Suppl. 1 (2019 Jan), s103–S123.
11. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults. Circulation 129 (2014), S102–S138.
12. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care 40:Suppl. 1 (2017 Jan), s11–S24.
13. Gaede, P, Lund-Anderson, H, Parving, HH, Pedersen, O, Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358 (2008), 580–591.
14. Fan, W, Song, Y, Inzucchi, SE, Sperling, L, Cannon, CP, Arnold, SV, Kosiborod, M, Wong, ND, Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: the diabetes collaborative registry. Diabetes Obes Metab 21 (2019), 1121–1127.
15. Espeland, M., Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 30 (2007), 1374–1383.
16. Malik, S, Wong, ND, Franklin, SS, Kamath, TV, L'Italien, GJ, Pio, JR, Williams, GR, Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110:10 (2004), 1245–1250.
17. American Heart Association. Heart Disease and Stroke Statistics-2019 At-A-Glance. 2019 Heart.org. https://professional.heart.org/idc/groups/ahamah-public/@wcm/@sop/@smd/documents/downloadable/ucm_503396.pdf. Published 2019.
18. Das, SR, Everett, BM, Birtcher, KK, Brown, JM, Cefalu, WT, Januzzi, JL Jr, Kalyani, RR, Kosiborod, M, Magwire, ML, Morris, PB, Sperling, LS, 2018 ACC expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a report of the American College of Cardiology task force on expert consensus decision pathways. J Am Coll Cardiol 72 (2019), 3200–3223.